Does Rasmussen's encephalitis have a cure?

Currently, there is no medical cure for Rasmussen’s encephalitis that can reverse the underlying inflammatory process or restore lost brain function. While curative options are limited, aggressive treatment strategies—most notably hemispherectomy—can effectively stop seizure activity and induce long-term remission in many patients.

Can Rasmussen’s encephalitis be treated?

While we lack a way to "cure" Rasmussen’s encephalitis, clinicians focus on halting the progressive neurological decline. Because Rasmussen’s encephalitis is characterized by chronic inflammation of one brain hemisphere, the goal is to manage symptoms and prevent further damage. Treatment typically involves a two-phase approach:

• Acute phase: Immunomodulatory therapies such as intravenous immunoglobulin (IVIG), steroids, or plasmapheresis are used to attempt to slow disease progression.


• Surgical phase: Functional or anatomical hemispherectomy remains the gold standard for long-term seizure control, often providing a permanent resolution to the seizures caused by Rasmussen’s encephalitis.

What does the future of research look like for Rasmussen’s encephalitis?

Researchers are currently investigating the autoimmune mechanisms of Rasmussen’s encephalitis to identify targeted therapies. Since we know that T-cell mediated cytotoxicity drives the neuronal loss in Rasmussen’s encephalitis, current studies are exploring biologics that can cross the blood-brain barrier to neutralize these specific immune cells without requiring invasive surgery.

Are there clinical trials for Rasmussen’s encephalitis?

Clinical trials for Rasmussen’s encephalitis are difficult to conduct due to the rarity of the condition. Current research is moving toward precision medicine, specifically focusing on:

1. Targeted immunosuppressants that inhibit specific inflammatory pathways.


2. Advanced neuroimaging to better predict which patients will benefit most from early surgical intervention.


3. Biomarker studies to identify Rasmussen’s encephalitis earlier, before significant cognitive decline occurs.

Next steps

• Consult with a specialized pediatric or adult neurologist/epileptologist at a major academic medical center.


• Connect with the 14 community members on DiseaseMaps.org to share experiences and coping strategies.


• Monitor ClinicalTrials.gov for updates on rare neuroinflammatory trials.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Rasmussen's encephalitis overview.


• Orphanet: Rare disease database entry for Rasmussen's encephalitis.


• OMIM (Online Mendelian Inheritance in Man): Clinical features and molecular research.


• Epilepsy Foundation: Resources for chronic inflammatory brain conditions.